![](https://investorshub.advfn.com/uicon/521970.png?cb=1579207683)
Wednesday, October 20, 2021 5:07:12 AM
This deal between Chemdiv, CureVac, and Eli Lilly is massive for all mRNA. And strikes so close to Regen IP that how does one not get excited? Its obvious demand for the exact type of IP that we hold thousands and thousands of hours of data in! And thru our exact same CRO, Chemdiv, that now BRG(big pharma FDA contractor) is suddenly evaluating too? Hello?
NR2F6 is becoming a front running mRNA study. Regen Biopharma owns a massive portion of NR2F6. Tic toc.
Some understand now. All will understand very very soon.
Sometimes its Skil, Sometimes its Luc.
I Appreciate All Member Follows!
Desperate Sellers Become Desperate Buyers. Vice Versa
ALL IMHO.
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM